140+
Products approved across 40+ countries
20+
Regulatory approvals Including USFDA, EU GMP, ANVISA, PIC/S, UAE
30+
Niche Products in pipeline across Cardiovascular, Diabetology, Urology and Hormones
Strong Presence
In Women’s Health, Complex Injectables, Ophthalmics, Dermatology, CVS & Metabolic
emerging market presence
Our Presence in
Overseas Market
Overseas Market
Since its inception, Mankind aspires to be customer-centric and a leader in the Global markets. Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society. Today, Mankind operates in 34 countries across the Globe.
Afghanistan
Algeria
Australia
Belgium
Brazil
Cambodia
Chile
China
Costa Rica
Denmark
Finland
France
Germany
Guatemala
Hong Kong
Indonesia
Iraq
Ireland
Jordan
Kenya
Lebanon
Malaysia
Mexico
Mongolia
Morocco
Myanmar
Nepal
Netherlands
New Zealand
Norway
Oman
Pakistan
Panama
Peru
Philippines
Poland
Russia
Saudi Arabia
Singapore
South Africa
Sri Lanka
Sweden
Tanzania
Thailand
UAE
Uganda
United Kingdom
Formulating business success
The emerging presence in Emerging Markets
Mankind’s innovative DNA comes to the fore in regulated emerging markets. Our pioneering R&D division has the capacity to develop niche molecules specific to emerging global markets. Over 26 niche products are currently in the pipeline at various stages of development, and more products are being regularly added.